TickerFacts.

InfuSystem Holdings, Inc (INFU): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$25.21M
Year ended 2025-12-31
$26.33M
Trailing 12 months to 2026-06-30
+18.9%
3-year compound annual growth
+2.0%
5-year compound annual growth
2018-12-31: $11.72M2019-12-31: $15.87M2020-12-31: $22.85M2021-12-31: $17.45M2022-12-31: $15.01M2023-12-31: $16.60M2024-12-31: $19.39M2025-12-31: $25.21M$25.21M
2018-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$25.21M+30.0%2026-02-27, From 2025-01-01
2024-12-31$19.39M+16.8%2026-02-27, From 2024-01-01
2023-12-31$16.60M+10.5%2025-03-11, From 2023-01-01
2022-12-31$15.01M-13.9%2024-04-10, From 2022-01-01
2021-12-31$17.45M-23.7%2024-04-10, From 2021-01-01
2020-12-31$22.85M+44.0%2023-03-16, From 2020-01-01
2019-12-31$15.87M+35.4%2022-03-15, From 2019-01-01
2018-12-31$11.72Mn/a2020-03-30, From 2018-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
InfuSystem Holdings, Inc (INFU)2025-12-31$25.21M+30.0%
Neuronetics, Inc. (STIM)2025-12-31-$27.97Mn/m
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$12.51Mn/m
Heartflow, Inc. (HTFL)2025-12-31-$58.63Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$61.78Mn/m
Anika Therapeutics, Inc. (ANIK)2025-12-31-$5.68Mn/m
SI-BONE, Inc. (SIBN)2025-12-31-$16.56Mn/m
Treace Medical Concepts, Inc. (TMCI)2025-12-31-$43.53Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$126.03Mn/m

Compare INFU, STIM, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗